Market Snapshot

BSE Sensex: 81332.72 1.62%
BSE 500: 36795.89 1.65%
BSE 200: 11475.13 1.74%
BSE 100: 26248.18 1.76%
BSE MidCap: 47706.67 2.12%
BSE SmallCap: 54294.35 1.00%
BSE BANKEX: 58638.77 0.86%
BSE IT: 41836.85 2.15%
Nifty 50: 24834.85 1.76%
Nifty 500: 23292.05 1.64%
Nifty 200: 14039.2 1.73%
Nifty 100: 25841.9 1.71%
Nifty Midcap 100: 57768.1 1.81%
Nifty Small 100: 18854 0.97%
Nifty IT: 40977.35 2.30%
Nifty PSU Bank: 7270.65 1.66%

News:

IndusInd Bank PAT rises to Rs ...
Cipla spurts as Q1 PAT rises 1...
Shriram Finance soars as Q1 PA...
Indus Towers spurts on buyback...
MMTC Ltd leads losers in A gro...

Lincoln Pharmaceuticals Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

Invest

26 Jul 2024 | 04:14 PM

652.35

9.30 (1.45%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Outperforms Index

54.99%

Return (1Y)

Beaten Nifty 50 by 29.42%
More Volatile

2.35%

Standard Deviation (1Y)

Higher than Nifty 50 by 1.54%
Consistent Performer

7/12

Months

beaten Nifty 50
AxisDirect View

No View

52 Week High-Low

755

406

News & Announcements

Lincoln Pharmaceuticals consolidated net profit rises 48.09% in the March 2024 quarter

71 days ago

Board of Lincoln Pharmaceuticals recommends Final Dividend
71 days ago

Board of Lincoln Pharmaceuticals recommends Final Dividend

16 - May - 2024 12:00 AM | 71 days ago

Lincoln Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 16 May 2024, has recommended a Final dividend of Rs.1.80 per share (i.e.18%), subject to the approval of the shareholders.
Powered by Capital Market - Live News
Lincoln Pharmaceuticals to announce Quarterly Result
78 days ago

Lincoln Pharmaceuticals to announce Quarterly Result

09 - May - 2024 12:00 AM | 78 days ago

Lincoln Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 16 May 2024
Powered by Capital Market - Live News
Lincoln Pharmaceuticals consolidated net profit rises 29.75% in the December 2023 quarter
169 days ago

Lincoln Pharmaceuticals consolidated net profit rises 29.75% in the December 2023 quarter

08 - Feb - 2024 12:00 AM | 169 days ago

Net profit of Lincoln Pharmaceuticals rose 29.75% to Rs 28.04 crore in the quarter ended December 2023 as against Rs 21.61 crore during the previous quarter ended December 2022. Sales rose 9.48% to Rs 146.45 crore in the quarter ended December 2023 as against Rs 133.77 crore during the previous quarter ended December 2022.
Particulars Quarter Ended
Dec. 2023 Dec. 2022 % Var.
Sales 146.45 133.77 9
OPM % 20.25 20.00 -
PBDT 40.52 32.78 24
PBT 37.71 30.51 24
NP 28.04 21.61 30
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

MF shareholding in Lincoln Pharmaceuticals Ltd has increased by 16.67% since past 3 Months
FII shareholding in Lincoln Pharmaceuticals Ltd has increased by 126.38% since past 1 Year
MF shareholding in Lincoln Pharmaceuticals Ltd has increased by 40% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended			Year Ended
	Mar. 2024	Mar. 2023	% Var.	Mar. 2024	Mar. 2023	% Var.
Sales	142.49	112.46	27	580.55	510.31	14
OPM %	12.90	14.80	-	17.21	17.48	-
PBDT	24.90	19.39	28	132.87	109.65	21
PBT	22.22	16.98	31	122.24	100.48	22
NP	18.60	12.56	48	93.30	72.90	28

Particulars	Quarter Ended
	Dec. 2023	Dec. 2022	% Var.
Sales	146.45	133.77	9
OPM %	20.25	20.00	-
PBDT	40.52	32.78	24
PBT	37.71	30.51	24
NP	28.04	21.61	30

General Notifications

My Notifications

Research Notifications

Lincoln Pharmaceuticals Ltd Share Price – NSE / BSE Pharmaceuticals, Small Cap

652.35 9.30 (1.45%)

News & Announcements

Price vs Volume

Stock Trivia

Lincoln Pharmaceuticals Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

652.35

9.30 (1.45%)